S89012 |
Mobocertinib |
MedMol | 98% |
- 产品描述: Mobocertinib (TAK788, AP32788) 是一种研究用的TKI,是有效的、选择性的 epidermal growth factor receptor (EGFR) 和 HER2 突变体的临床前抑制剂。Mobocertinib (TAK788) 是一种抗肿瘤药
- 靶点: EGFR;HER2
- 体内研究: Mobocertinib suppresses growth of EGFRex20ins mutant tumors through EGFR inhibition. Combination treatment with mobocertinib and cetuximab improves efficacy in a head and neck squamous cell carcinoma model (CTG-2130) with EGFRex20ins D770_N771insGL.
- 细胞实验: Cell lines: NSCLC cell lines, Ba/F3 cells, A431 Cells, HEK293 cells Concentrations: 0.0003 -1 µM Incubation Time: 30 min, 2 h, 6h, 7 days Method: Cells are plated into 96-well plates and dosed with a nine-point, threefold dilution series of compounds and incubated for 7 days. Viability is measured using the CellTiter-Glo assay. Dose–response curves are generated and used to calculate IC50 values.
- 参考文献:
1. Gonzalvez F, et al. Cancer Discov. 2021 Jul;11(7):1672-1687. 2. Landon J. DURAK, et al. WO 2019/222093 A1.
- 溶解性: Soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 1.707 ml 8.537 ml 17.074 ml 5 mM 0.341 ml 1.707 ml 3.415 ml 10 mM 0.171 ml 0.854 ml 1.707 ml 50 mM 0.034 ml 0.171 ml 0.341 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)